Emergent pathogen as Purpureocillium lilacinum are becoming cause of morbidity and mortality in our population, especially in immunocompromised patients. We describe a case of hyalohyphomycosis in a diabetic man under systemic steroid treatment for a bullous pemphigoid. Treatment with different antimycotic drugs were ineffective and infection spread diffusely, leading to deterioration of general conditions and ultimately death. The aim of this article is to increase awareness of clinicians about this uncommon, but frequently fatal refractory mycotic infection.
Fatal hyalohyphomycosis with cutaneous involvement caused by purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid
Ferreli C.Secondo
Writing – Original Draft Preparation
;Atzori L.Membro del Collaboration Group
;Pilloni L.Penultimo
Membro del Collaboration Group
;Rongioletti F.Ultimo
Supervision
2021-01-01
Abstract
Emergent pathogen as Purpureocillium lilacinum are becoming cause of morbidity and mortality in our population, especially in immunocompromised patients. We describe a case of hyalohyphomycosis in a diabetic man under systemic steroid treatment for a bullous pemphigoid. Treatment with different antimycotic drugs were ineffective and infection spread diffusely, leading to deterioration of general conditions and ultimately death. The aim of this article is to increase awareness of clinicians about this uncommon, but frequently fatal refractory mycotic infection.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
fatal jalohyphomicosis ACTA-93-139.pdf
accesso aperto
Tipologia:
versione editoriale (VoR)
Dimensione
557.68 kB
Formato
Adobe PDF
|
557.68 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.